Features

Influence of Mediterranean-Style Diet on AMD

Our findings suggest certain dietary and lifestyle habits may confer long-term protective benefits.

Christopher Phung, BA; Beryl Zhou, BS; Robert Luca, BA; and Dimitra Skondra, MD, PhD

Predicting Progression to GA Using Imaging Biomarkers

Several OCT findings can help clinicians better understand a patient’s risk of progression to sight-threatening disease.

Kelly Donovan, MD, PhD, and Eleonora M. Lad, MD, PhD

PBM for AMD: Mechanisms, Evidence, and Clinical Integration

Photobiomodulation shows promise, but long-term data are needed.

Luis Acabá-Berrocal, MD, and Anton Orlin, MD

Novel MOAs in Wet AMD

The pipeline is full of therapies that hold promise for extending treatment efficacy.

Lejla Vajzovic, MD, FASRS; Robert L. Avery, MD; Carl D. Regillo, MD; and Durga S. Borkar, MD, MMCi

Pearls and Pitfalls of Treating GA and Wet AMD

Concurrent therapy can pose clinical challenges. Here’s how you can manage these patients and maximize outcomes.

Sean D. Adrean, MD, FAAO, and Wesley Han, BS

Landmark Trials in AMD

A summary of the clinical trials that have shaped—and continue to shape—how we treat AMD.

Saghar Bagheri, MD, PHD; Alberto Quarta, MD; Rouzbeh Abbasgholizadeh, MD; Alessandro Feo, MD; Paolo Forte, MD; David Sarraf, MD; Michael S. Ip, MD; and SriniVas R. Sadda, MD, FARVO

Anti-VEGF Step Therapy: An Update

Despite ongoing advocacy efforts, this payer policy persists, putting vision at risk.

Lucas McGuire, BS; Baseer Ahmad, MD; and Jennifer Adeghate, MD, PhD

Widefield OCT: Extending Structural Imaging into the Periphery

These new tools are improving our view.

Alberto Quarta, MD; Ceren Soylu, MD; and SriniVas R. Sadda, MD, FARVO

Imaging Epiretinal Proliferation Using OCT

En face OCT–based identification of proliferative changes may guide surgical strategies in full-thickness macular holes.

Kotaro Tsuboi, MD

Clinical Applications of Microscope-Integrated OCT

Recent advances have improved the utility of intraoperative visualization, with more innovation on the way.

Bani Aguirre, MD, MPH; Anjali Saini, BS; Vahid Ownagh, MD; and Lejla Vajzovic, MD

OR Tech Update: 3D Displays, AI, and Robotics

New visualization tools are expanding what’s possible in the OR.

Kareena Chawla, BS; Jayanth Sridhar, MD; and Prashant D. Tailor, MD

The Value of OCTA in Retinal Vascular Disease

Measuring retinal blood flow is easier than ever before, with new tools under investigation to further improve our ability to assess changes in the retinal vasculature.

Sarah Aman, MD; Viet-Hoan Le, PhD; Ruikang K. Wang, PhD; and Amir H. Kashani, MD, PhD

Parenting and Private Practice: Balance Isn't Everything

Strategies to stay organized, and clinical challenges to address.

Jaya Badhwar Kumar, MD, FASRS

Teleretinal Screening: Closing the Gap in Diabetic Eye Care

Meeting patients where they are—community health centers—can improve screening rates and save vision.

Alice C. Lorch, MD, MPH

How To Increase Diversity on the Podium

Who is presenting matters; it shapes the profession and the aspirations of trainees.

Melissa Yuan, MD; Eugenia C. Greig, MD; and Carolyn K. Pan, MD

Mentoring Retina Fellows From All Walks of Life

Training to become a retina specialist is an expensive endeavor. Here’s how mentors and programs can help support trainees economically.

Katherine E. Talcott, MD; Yoshihiro Yonekawa, MD; and Adrienne W. Scott, MD, FASRS

Focus on Diversity in Clinical Trials

Improving representation moves us closer to an era of personalized medicine.

Jeremiah Brown Jr, MD, MS, FASRS, and Genevieve Espinoza, BA, COA, OSC

The New Retina OR: The Latest Vitrectomy Tools

New platforms and instruments can help improve surgical efficiency and patient outcomes.

María H. Berrocal, MD; Luis Acabá-Berrocal, MD; Priya Vakharia, MD, FASRS; David Steel MBBS, FRCOphth, MD(Res); and MitroFanis Pavlidis, MD, PhD

Tips and Tricks for Scleral-Fixating Toric IOLs

Small adjustments to your surgical technique can help you meet your patients’ refractive goals.

Barton L. Blackorby, MD

Current Subretinal Gene Therapy Delivery

This technique may become more mainstream as new therapies work through the pipeline.

Nell (Ninel) Gregori, MD